Hepatitis C is an infection of the liver caused by the hepatitis C virus (HCV). Experts estimate that about 2.4 million people in the United States are living with hepatitis C—but that figure could be ...

A typical course of Sovaldi costs $84,000, but the manufacturer says it will save money long term. Insurers are trying to figure out who should get it. A new “miracle drug” is raising eyebrows across ...

A Wigan and Leigh drug and alcohol charity has been able to announce the micro-elimination of hepatitis C ahead of the NHS 2030 target.

A new report questions the safety of some of the new drugs found to cure hepatitis C, in light of findings of liver failure and injury. But hepatitis C virus (HCV) experts say the findings are ...

Medicare Part D or MAPD plans should cover hepatitis C medications, but the exact covered drugs depend on the plan. Infused drugs and other treatments are covered by Original Medicare (parts A and B) ...

People with hepatitis C virus who inject drugs could be evaluated for cure approximately 2 months earlier than current ...

March 12 (Reuters) - U.S. regulators have accepted Bristol-Myers Squibb Co's re-submitted marketing application for an experimental hepatitis C treatment after the drugmaker was forced last year to ...

Hepatitis C virus (HCV) reinfection rates among people who inject drugs are high immediately after treatment in community settings, particularly among those reporting recent injection drug use and ...

LONDON (Reuters) - Frustrated by the high price of antiviral drugs, thousands of patients from London to Moscow to Sydney are turning to a new wave of online "buyers clubs" to get cheap generic ...

Please provide your email address to receive an email when new articles are posted on . Use of illicit fentanyl increased injection drug users’ risk for hepatitis C by more than 60%. The finding has ...

On Wednesday, Florida health officials changed the state’s policy for administering expensive hepatitis C drugs to Medicaid patients, now requiring insurance companies to provide the drug at an ...